Debt swapped for equity at 30c a share. Current share price 14c. Company is constrained for growth because it is at 100% production. What I can see, I like. Topping up Monday.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025